Fig. 1: Sustainable AMR treatment development workflow.
From: Flash optimization of drug combinations for Acinetobacter baumannii with IDentif.AI-AMR
The IDentif.AI workflow begins with engaging with clinical teams to shortlist the initial pool of drugs for IDentif.AI analysis. Subsequently, IDentif.AI harnesses the experimental data derived from a small set of experiments to rapidly pinpoint effective combinations against the bacteria. IDentif.AI-pinpointed top combinations are experimentally validated. This workflow may sustainably accelerate the development of A. baumannii and other AMR-specific treatment strategies.
